Literature DB >> 15969593

The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge.

Davide Branduardi1, Francesco Luigi Gervasio, Andrea Cavalli, Maurizio Recanatini, Michele Parrinello.   

Abstract

We study the ligand (tetramethylammonium) recognition by the peripheral anionic site and its penetration of the human AChE gorge by using atomistic molecular dynamics simulations and our recently developed metadynamics method. The role of both the peripheral anionic site and the formation of cation-pi interactions in the ligand entrance are clearly shown. In particular, a simulation with the W286A mutant shows the fundamental role of this residue in anchoring the ligand at the peripheral anionic site of the enzyme and in positioning it prior to the gorge entrance. Once the ligand is properly oriented, the formation of specific and synchronized cation-pi interactions with W86, F295, and Y341 enables the gorge penetration. Eventually, the ligand is stabilized in a free energy basin by means of cation-pi interactions with W86.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969593     DOI: 10.1021/ja0512780

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

Review 1.  Flexibility and binding affinity in protein-ligand, protein-protein and multi-component protein interactions: limitations of current computational approaches.

Authors:  Pierre Tuffery; Philippe Derreumaux
Journal:  J R Soc Interface       Date:  2011-10-12       Impact factor: 4.118

2.  Insight into the folding inhibition of the HIV-1 protease by a small peptide.

Authors:  Massimiliano Bonomi; Francesco L Gervasio; Guido Tiana; Davide Provasi; Ricardo A Broglia; Michele Parrinello
Journal:  Biophys J       Date:  2007-06-15       Impact factor: 4.033

3.  Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.

Authors:  Fang Bai; Yechun Xu; Jing Chen; Qiufeng Liu; Junfeng Gu; Xicheng Wang; Jianpeng Ma; Honglin Li; José N Onuchic; Hualiang Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

4.  Using metadynamics to understand the mechanism of calmodulin/target recognition at atomic detail.

Authors:  G Fiorin; A Pastore; P Carloni; M Parrinello
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

5.  Energetics of Ortho-7 (oxime drug) translocation through the active-site gorge of tabun conjugated acetylcholinesterase.

Authors:  Vivek Sinha; Bishwajit Ganguly; Tusar Bandyopadhyay
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

6.  The immunomodulation of acetylcholinesterase in zhikong scallop Chlamys farreri.

Authors:  Xiaowei Shi; Zhi Zhou; Lingling Wang; Feng Yue; Mengqiang Wang; Chuanyan Yang; Linsheng Song
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 7.  The use of hammett constants to understand the non-covalent binding of aromatics.

Authors:  Michael Lewis; Christina Bagwill; Laura K E Hardebeck; Selina Wireduaah
Journal:  Comput Struct Biotechnol J       Date:  2012-03-06       Impact factor: 7.271

Review 8.  Accounting for receptor flexibility and enhanced sampling methods in computer-aided drug design.

Authors:  William Sinko; Steffen Lindert; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

9.  High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive sampling.

Authors:  Théo Jaffrelot Inizan; Frédéric Célerse; Olivier Adjoua; Dina El Ahdab; Luc-Henri Jolly; Chengwen Liu; Pengyu Ren; Matthieu Montes; Nathalie Lagarde; Louis Lagardère; Pierre Monmarché; Jean-Philip Piquemal
Journal:  Chem Sci       Date:  2021-02-02       Impact factor: 9.825

10.  Secondary Structure of Rat and Human Amylin across Force Fields.

Authors:  Kyle Quynn Hoffmann; Michael McGovern; Chi-Cheng Chiu; Juan J de Pablo
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.